Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Mycol Med ; 30(1): 100919, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31901425

RESUMEN

We evaluated the in vitro activity of miltefosine against 29 Pythium spp. and the in vivo therapeutic response of 2mg/kg/day of miltefosine given orally to rabbit with pythiosis induced experimentally. The MICs (in µg/mL) of miltefosine was medium-dependent and ranged from 0.5 to 2 and 32-64 on RPMI 1640 and Mueller Hinton broth, respectively. The treatment with miltefosine demonstrated significantly lower subcutaneous lesion areas compared to the control group but was not sufficient for the complete remission of the lesions. This study indicates that miltefosine has limited efficacy against pythiosis and furthers in vitro and in vivo studies are necessary to determine the possible potential of this drug in the treatment of pythiosis.


Asunto(s)
Antifúngicos/uso terapéutico , Dermatomicosis/tratamiento farmacológico , Fosforilcolina/análogos & derivados , Pitiosis/tratamiento farmacológico , Animales , Dermatomicosis/microbiología , Dermatomicosis/patología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Pruebas de Sensibilidad Microbiana , Fosforilcolina/uso terapéutico , Pitiosis/microbiología , Pitiosis/patología , Pythium/aislamiento & purificación , Pythium/patogenicidad , Conejos , Tejido Subcutáneo/microbiología , Resultado del Tratamiento
2.
J Mycol Med ; 25(1): 91-4, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25459680

RESUMEN

This study evaluated the in vitro and in vivo activity of micafungin alone and in combination with the iron chelator deferasirox against Pythium insidiosum. Micafungin showed a poor in vitro activity when it was used alone, but synergistic interactions were observed for 88.2% of the strains when the drug was combined with deferasirox. Smaller lesions were observed in infected rabbits receiving the combination therapy, although it favored disease dissemination to the lungs. The present results show that micafungin alone is ineffective against P. insidiosum, and the combination micafungin-deferasirox might have deleterious effects for the host.


Asunto(s)
Benzoatos/administración & dosificación , Equinocandinas/administración & dosificación , Lipopéptidos/administración & dosificación , Pitiosis/tratamiento farmacológico , Pythium/efectos de los fármacos , Triazoles/administración & dosificación , Animales , Antifúngicos/administración & dosificación , Deferasirox , Modelos Animales de Enfermedad , Quimioterapia Combinada , Femenino , Enfermedades de los Caballos/tratamiento farmacológico , Enfermedades de los Caballos/microbiología , Caballos , Micafungina , Pruebas de Sensibilidad Microbiana , Pitiosis/microbiología , Pythium/crecimiento & desarrollo , Conejos
3.
Br Poult Sci ; 55(2): 215-20, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24423730

RESUMEN

1. The protective effect of a natural Brazilian calcium montmorillonite (CaMont) against aflatoxins was studied in broiler chickens. 2. A total of 1056-d-old Cobb male broilers were housed in experimental pens (22 chickens per pen) for 42 d. Three levels of CaMont (0, 2.5 and 5 g/kg) and two levels of aflatoxins (0 and 3 mg/kg) were assayed. Each treatment had 8 replicate pens of 22 broiler chickens each. 3. Of all the chickens tested in the experiment, the ones treated with aflatoxins were the most adversely affected. CaMont treatment at concentrations of 2.5 and 5 g/kg improved body weight of chickens at 42 d of age by 13.3% and 22.7%, increased daily feed intake by 9.7% and 24.7%, and improved the productive efficiency index of chickens by 53% and 66.5%, respectively. 4. Dietary CaMont positively affected parameters such as weight of liver, heart and gizzard; however, serum potassium concentration decreased by 15.3% compared with that of chickens given only the aflatoxin-contaminated diet. 5. CaMont did not cause adverse effects in chickens that did not receive aflatoxins. 6. CaMont at pH 8.5 partially reduced the toxic effects of aflatoxins in broilers when included at levels of 2.5 and 5 g/kg in the diet.


Asunto(s)
Aflatoxinas/metabolismo , Bentonita/farmacología , Peso Corporal/efectos de los fármacos , Calcio de la Dieta/farmacología , Pollos/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Aflatoxinas/toxicidad , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Masculino , Distribución Aleatoria
4.
J Antimicrob Chemother ; 68(5): 1144-7, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23329785

RESUMEN

OBJECTIVES: Iron plays an important role in the pathogenesis of Pythium insidiosum. Human pythiosis frequently occurs in iron-overloaded thalassaemic patients and experimentally infected animals develop iron deficiency anaemia. Therefore, we sought to determine the in vitro and in vivo activities of the iron chelator deferasirox against P. insidiosum. METHODS: In vitro, the MIC and minimum fungicidal concentration (MFC) values of deferasirox for 17 strains of P. insidiosum were determined in accordance with CLSI document M38-A2. In vivo studies were carried out in 20 inoculated rabbits divided into four groups: placebo, immunotherapy obtained from vortexed P. insidiosum cultures (14 day intervals), deferasirox (15 mg/kg/day) and a combination of immunotherapy and deferasirox. Five non-infected animals were used as controls. RESULTS: The MIC and MFC values of deferasirox for P. insidiosum ranged from 12.5 to 50 mg/L and from 50 to 100 mg/L, respectively. Treatment with deferasirox alone ameliorated anaemia and normalized the serum iron levels and hepatic iron concentration in the animals. However, the mean lesion size, although decreased, did not differ significantly from that in the placebo group. The results of immunotherapy plus iron chelation therapy were worse than those of immunotherapy alone. Moreover, the disease spread to the lung tissue in 5 out of 10 deferasirox-treated animals. CONCLUSIONS: Despite its limited in vitro and in vivo activity, deferasirox improved iron deficiency anaemia in P. insidiosum-infected rabbits. Further studies are needed to investigate the immunomodulatory properties observed in this study and the benefits and drawbacks of using iron-chelating drugs as an adjuvant therapy in pythiosis.


Asunto(s)
Benzoatos/administración & dosificación , Terapia por Quelación/métodos , Quelantes del Hierro/administración & dosificación , Hierro/metabolismo , Pitiosis/tratamiento farmacológico , Pythium/aislamiento & purificación , Triazoles/administración & dosificación , Animales , Anticuerpos Antifúngicos/administración & dosificación , Deferasirox , Femenino , Inmunoterapia/métodos , Pruebas de Sensibilidad Microbiana , Modelos Animales , Pythium/efectos de los fármacos , Conejos , Resultado del Tratamiento
5.
Biometals ; 24(2): 349-56, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21207116

RESUMEN

Syzygium cumini (L.) Skeels (Sc) belongs to the medicinal plants with an important source of phenolic compounds. Sc has been shown to possess antioxidant and anti-inflammatory properties. Methylmercury (MeHg), a highly toxic environmental pollutant, induces oxidative stress and dysfunction in many cell types. This study was aimed to evaluate the effect of aqueous seed extract of Sc (ASc) on MeHg-induced toxicity in rats. Two-day-old rats (P2) received a single dose of MeHg (10 mg/kg) and two doses of ASc (0.9 mg/kg) per os. After two days, the effects of the treatment were investigated in the cerebral cortex, hippocampus, kidney, liver and urine samples. Our results demonstrated that N-acetyl-ß-D: -glucosaminidase (NAG) activity in the kidney and urine, the lipid peroxidation levels in the liver and kidney samples, as well as the adenosine deaminase (ADA) activity in the hippocampus, kidney and liver were higher in MeHg-group when compared to the control group. The administration of ASc reverted the toxic effects of MeHg. It is noteworthy to observe that the main compounds present in the ASc, as gallic acid (the major component), chlorogenic acid and rutin, might be the responsible for such benefit, since they were found to display antioxidant properties.


Asunto(s)
Compuestos de Metilmercurio/toxicidad , Extractos Vegetales/farmacología , Semillas/química , Syzygium/química , Adenosina Desaminasa/metabolismo , Animales , Animales Recién Nacidos , Peso Corporal/efectos de los fármacos , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Cromatografía Líquida de Alta Presión , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratas , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA